0001144204-14-069949.txt : 20141120 0001144204-14-069949.hdr.sgml : 20141120 20141120093531 ACCESSION NUMBER: 0001144204-14-069949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141118 FILED AS OF DATE: 20141120 DATE AS OF CHANGE: 20141120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sevion Therapeutics, Inc. CENTRAL INDEX KEY: 0001035354 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 841368850 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 721 ROUTE 202/206, STREET 2: SUITE 130 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-864-4444 MAIL ADDRESS: STREET 1: 721 ROUTE 202/206, STREET 2: SUITE 130 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC DATE OF NAME CHANGE: 19991006 FORMER COMPANY: FORMER CONFORMED NAME: NAVA LEISURE USA INC DATE OF NAME CHANGE: 19970310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Browne Leslie J CENTRAL INDEX KEY: 0001300293 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31326 FILM NUMBER: 141237718 MAIL ADDRESS: STREET 1: P.O. BOX 5350 CITY: PRINCETON STATE: NJ ZIP: 08543-5350 4 1 form471638_20141120093430-.xml X0306 4 2014-11-18 0 0001035354 Sevion Therapeutics, Inc. SVON 0001300293 Browne Leslie J 721 ROUTE 202/206 SUITE 130 BRIDGEWATER NJ US 08807 0 1 0 0 President Common Stock Option (right to buy) 0.83 2014-11-18 4 A 0 42210 0 A 2015-11-18 2024-11-18 Common Stock 42210 82065 D The options vest in a two-step process. First, options vest based on the attainment of pre-established corporate and individual performance goals. Second, the options that are earned based on the attainment of performance goals will vest as follows: 25% on the first anniversary of the date of grant with the balance vesting at a rate of 1/36 per month thereafter, subject to the executive officer's continued service through each applicable vesting date, provided, however, that pursuant to Dr. Browne's Retention Agreement, such option will fully vest if Dr. Browne's employment is terminated by the Company without cause. No options will vest if the Company's compensation committee has determined that the performance metrics have not been met. Such option grant was approved by the Company's compensation committee in September 2014 and, consistent with prior practice, was granted on the second business day following the Company's filing of its quarterly report on Form 10-Q for the period ending September 30, 2014. Leslie J. Browne 2014-11-20